Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ArQule Inc (NASDAQ:ARQL)

1.11
Delayed Data
As of 3:59pm ET
 -0.02 / -1.77%
Today’s Change
0.92
Today|||52-Week Range
1.68
-11.90%
Year-to-Date
No recent news for ArQule Inc.

Today’s Trading

Previous close1.13
Today’s open1.13
Day’s range1.09 - 1.15
Volume516,917
Average volume (3 months)137,735
Market cap$80.4M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-31.31%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-58.10%
P/E ratioNM
Price/Sales18.65
Price/Book3.40

Competitors

 Today’s
change
Today’s
% change
EIGREiger BioPharmaceuti...+0.55+4.49%
LPCNLipocine Inc-0.12-3.13%
MRNSMarinus Pharmaceutic...+0.19+3.72%
CEMIChembio Diagnostics ...0.000.00%
Data as of 4:00pm ET, 10/20/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$4.7M
Annual profit (last year)-$22.7M
Net profit margin-482.44%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Paolo Pucci
President, Chief Operating Officer &
Secretary
Peter S. Lawrence
Corporate headquarters
Burlington, Massachusetts

Forecasts